Bioengineered Surfactant Program

About BioSuperior

BioSuperior is a private, preclinical-stage biotech targeting significant unmet needs in respiratory care through bioengineered lung surfactants. The company's platform technology seeks to overcome the limitations of current animal-derived surfactant therapies by designing products with enhanced stability, efficacy, and potentially broader applicability. While still in early development and pre-revenue, BioSuperior is positioned in a large and growing market for acute and chronic respiratory distress. Success hinges on translating its innovative platform into clinical candidates and securing partnership or funding to advance through costly development phases.

About BioSuperior

BioSuperior is a private, preclinical-stage biotech targeting significant unmet needs in respiratory care through bioengineered lung surfactants. The company's platform technology seeks to overcome the limitations of current animal-derived surfactant therapies by designing products with enhanced stability, efficacy, and potentially broader applicability. While still in early development and pre-revenue, BioSuperior is positioned in a large and growing market for acute and chronic respiratory distress. Success hinges on translating its innovative platform into clinical candidates and securing partnership or funding to advance through costly development phases.

Therapeutic Areas